Fresh analysis indicates that individuals who discontinue blockbuster weight-loss injections like semaglutide or tirzepatide may regain lost weight at a significantly accelerated pace than those who stop conventional diet and exercise programs.
Published data in a prominent medical journal demonstrates that while obese individuals can lose about a fifth of their total mass while on the medication, the weight is regained at an average rate of nearly a kilo each month after stopping.
"Individuals using these medications need to be informed of the danger of quick weight regain when the medication is stopped," cautioned expert Dr. Susan Jebb.
Such speed of recovery suggests a return to starting weight within about a year and a half.
Analyzing Approaches
The analysis, which examined dozens of trials involving thousands of patients, contrasted the effects of the injectable medications with other pills.
Scientists note that individuals who shed pounds through lifestyle changes alone usually see a less rapid creep back—perhaps 0.1 kg a month—post-intervention.
The Reason for the Quick Regain
Experts believe the mode of action of the jabs is key to understanding the amplified weight return.
GLP-1 drugs imitate a body's own chemical called GLP-1, which helps regulate feelings of fullness.
"Artificially providing the hormone concentrations several times higher than the body's typical production might result in the body to generate a reduced amount of its endogenous hormone, and may also lessen responsiveness to its effects," said Dr. Adam Collins, a nutrition specialist.
"Withdrawal of this GLP-1 'fix' leads to appetite is no longer kept in check, making excessive eating much more probable."
A Chronic Issue?
Health authorities advise the jabs for people with weight-linked medical conditions, alongside recommended lifestyle changes.
Many experts say that, considering the high risk of weight regain, the treatment is often life-long.
This perspective is echoed by drug manufacturers, who say that the findings "emphasize the persistent nature of excess weight," comparing it to managing conditions like high blood pressure.
Patient Experiences
People who have come off the jabs describe a intense return of cravings.
"I experienced something activating and I was suddenly starving," recalled a patient.
This challenge is compounded if users have not established permanent dietary or behavioural changes during treatment.
Growing Adoption
Figures show that millions of adults in the UK have used weight-loss jabs in the last 12 months, with interest continuing to grow.
- Adoption is higher among women than men.
- The middle-aged age group shows the highest level of interest.
- Many obtain the medications through private prescriptions rather than public health services.
Finally, clinicians caution that while these medications are powerful tools for shedding pounds, they are not a standalone cure and lasting health benefits hinges on combined behavioural changes.
